期刊文献+

多烯磷脂酰胆碱胶囊联合复方益肝灵胶囊治疗抗结核药物致肝损伤患者的临床疗效 被引量:8

Antituberculosis Drug-Induced Liver Injury:Clinical Efficacy of Polyene Phosphatidylcholine Capsule and Compound Yiganling Capsule
原文传递
导出
摘要 目的:研究多烯磷脂酰胆碱胶囊联合复方益肝灵胶囊治疗抗结核药物致肝损伤患者的临床疗效。方法:选取2014年4月到2015年4月我院收治的抗结核药物致肝损伤患者150例,按照随机数字表法将患者分为研究组和对照组,每组75例,两组均继续行抗结核治疗,对照组给予常规保肝药物治疗,研究组给予多烯磷脂酰胆碱胶囊联合复方益肝灵胶囊保肝治疗,比较两组临床疗效,治疗前后谷丙转氨酶(ALT)、谷草转氨酶(AST)以及r-谷氨酰转移酶(r-GT)。结果:研究组有效率为89.3%显著高于对照组的73.3%,两组比较差异具有统计学意义(P<0.05);两组治疗后AST、ALT以及r-GT显著低于治疗前,且治疗后研究组AST、ALT以及r-GT均显著低于对照组,比较差异均具有统计学意义(均P<0.05)。结论:多烯磷脂酰胆碱胶囊联合复方益肝灵胶囊治疗抗结核药物致肝损伤具有较好临床疗效,能增强对肝脏的保护作用。 Objective: To study the clinical efficacy of polyene phosphatidylcholine capsule combined with compound Yiganling capsule in treatment of antituberculosis drug-induced liver injury. Methods: A total of 150 patients with antituberculosis drug-induced liver injury, who were admitted to 425 Hospital of People's Liberation Army fxom April 2014 to April 2015, were selected and randomly divided into study group (n=75) and control group (n=75). The control group was treated with conventional liver protection drugs, while the study group, with polyene phosphatidylcholine capsule combined with compound Yiganling capsule. The clinical efficacy and the levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST) and r-glutamyl transferase(r-GT) in the two groups before and after treatment were compared. Results: The effective rate(89.3%) of study group was significantly higher than that(73.3%) of the control group, the difference was statistically significant (P〈0.05). The levels of AST, ALT and rGT of two groups after treatment were significantly lower than before treatment, and the levels of AST, ALT and rGT of study group after treatment were significantly lower than those of control group, the differences were statistically significant (P〈0.05). Conclusion: Polyene phosphatidylcholine capsule plus compound Yiganling capsule has a better clinical efficacy in the treatment of patients with antituberculosis drug-induced liver injury, which can enhance the protective effect on the liver.
出处 《现代生物医学进展》 CAS 2016年第4期727-729,共3页 Progress in Modern Biomedicine
关键词 多烯磷脂酰胆碱胶囊 复方益肝灵胶囊 抗结核药物 肝损伤 Polyene phosphatidylcholine capsule Compound Yiganling capsule Antituberculosis drug Liver injury
  • 相关文献

参考文献3

二级参考文献59

  • 1谭卫国,杨应周,罗道泉,吴清芳,张玉华,罗育希.深圳市结核分枝杆菌耐药监测疫情趋势分析[J].中华检验医学杂志,2005,28(8):805-806. 被引量:18
  • 2Word Health Organization/Internationgal Union Against Tuberculosis and Lung Disease. Guideline for surveil-lance of drug resistance in tuberculosis [ S ]. Ceneva: WHO, 1997.
  • 3卫生部疾控司.中国结核病防治规划实施T作指南[M].北京:卫生部,2002.
  • 4人民卫生出版社.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:卫生部,2010:49.
  • 5Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of nonalcoholicfatty liver disease: practice Guideline by the AmericanAssociation for the Study of Liver Diseases, American Collegeof Gastroenterology, and the American GastroenterologicalAssociation. Hepatology 2012; 55: 2005-2023 [PMID: 22488764DOI: 10.1002/hep.25762].
  • 6Rozman D. From nonalcoholic Fatty liver disease to hepatocellularcarcinoma: a systems understanding. Dig Dis Sci 2014; 59: 238-241[PMID: 24385011 DOI: 10.1007/s10620-013-2998-x].
  • 7Arendt BM, Allard JP. Effect of atorvastatin, vitamin E and C onnonalcoholic fatty liver disease: is the combination required- Am JGastroenterol 2011; 106: 78-80 [PMID: 21212755 DOI: 10.1038/ajg.2010.310].
  • 8Pamuk GE, Sonsuz A. N-acetylcysteine in the treatment ofnonalcoholic steatohepatitis. J Gastroenterol Hepatol 2003; 18:1220-1221 [DOI: 10.1046/j.1440-1746.2003.03156.x].
  • 9Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-BladouC, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J. A randomizedcontrolled trial of high-dose ursodesoxycholic acid for nonalcoholicsteatohepatitis. J Hepatol 2011; 54: 1011-1019 [PMID: 21145828DOI: 10.1016/j.jhep.2010.08.030].
  • 10Bell LN, Wang J, Muralidharan S, Chalasani S, Fullenkamp AM,Wilson LA, Sanyal AJ, Kowdley KV, Neuschwander-Tetri BA, BruntEM, McCullough AJ, Bass NM, Diehl AM, Unalp-Arida A, ChalasaniN. Relationship between adipose tissue insulin resistance and liverhistology in nonalcoholic steatohepatitis: a pioglitazone versusvitamin E versus placebo for the treatment of nondiabetic patients withnonalcoholic steatohepatitis trial follow-up study. Hepatology 2012;56: 1311-1318 [PMID: 22532269 DOI: 10.1002/hep.25805].

共引文献23

同被引文献74

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部